FDA approves Moderna and J&J boosters, as well as a “mix and match” approach


The Food and Drug Administration cleared booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines on Wednesday, and also said it was acceptable to mix and match the initial and booster doses.

Under the Emergency Use Authorization, half a dose of Moderna vaccine can be given as a booster to people 65 years of age and older who have been fully vaccinated for at least six months, as well as people 18 years and older who are at high risk of severe COVID. -19 or are frequently exposed to COVID-19 in their workplace. As a reminder Johnson & Johnson, it can be given to adults 18 years of age and older, at least two months after receiving their initial single dose of the vaccine.

“As the pandemic continues to impact the country, science has shown that vaccination continues to be the safest and most effective way to prevent COVID-19, including the most serious consequences of illness, such as hospitalization and death, “Acting FDA Commissioner Dr. Janet Woodcock said in a statement. “Available data suggests decreased immunity in some fully vaccinated populations. The availability of these authorized boosters is important for continued protection against COVID-19 disease.”

On Thursday, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will meet and determine whether to recommend FDA clearance. Then CDC director Rochelle Walensky will decide whether to endorse their advice.

Leave A Reply

Your email address will not be published.